XBI ETF Analysis - Small-Cap Biotech Comeback Fueled by Policy Shifts
Federal policy changes have reduced structural risk for small-cap biotech. The One Big Beautiful Bill Act preserved no-negotiation status for rare-di…
Independent equity research, trades, and weekly market notes.
Federal policy changes have reduced structural risk for small-cap biotech. The One Big Beautiful Bill Act preserved no-negotiation status for rare-di…
A federal action authorized the restart of a long-dormant California coastal oil pipeline formerly run by ExxonMobil now owned by Sable Offshore. Sab…
The Iran conflict has expanded into a multi-week engagement with White House officials considering American boots on the ground. The VIX closed above…
Geopolitical escalation in the Middle East is raising volatility and favoring energy producers while squeezing broader sectors through higher input a…
Northrop Grumman is central to stealth platforms, nuclear modernization, and advanced missile defense. Catalysts include accelerated B-21 production …
ARM released its first data center chip after years of licensing semiconductor intellectual property. The company has begun selling processors in add…
Caterpillar is a long standing blue chip with a history of dividend payments and membership in the S&P 500 and Dow Jones. The company plans for half …
The Federal Reserve faces persistent inflation alongside signs of a weakening labor market while oil prices have risen sharply. Geopolitical conflict…
Energy Recovery supplies devices that recover and reuse energy in seawater desalination. Ethos Technologies offers an AI-driven life insurance platfo…
The Fed must balance persistent inflation and a softening labor market while rising oil and geopolitical conflict in the Middle East drive uncertaint…
Feed